Clinical Trial Update: Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic stem cell transplantation with dose-reduced conditioning in patients with myelofibrosis; the study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Myelofibrosis | Phase 2 | Status: COMPLETED